Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -3227.91%, near the high end of its 5-year range (-235539.83%–17059.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 75.25%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
75.25%
OPERATING MARGIN AVG 3Y
-6082.77%
OPERATING MARGIN AVG 5Y
-3227.91%
OPERATING MARGIN AVG 10Y
-2378.26%
OPERATING MARGIN AVG 15Y
-475.28%
OPERATING MARGIN AVG 20Y
-3431.43%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ABVC BioPharma, Inc.
Market Cap
$25.48M
Operating Margin
0.00%
TTM Avg
75.25%
3Y Avg
-6082.77%
5Y Avg
-3227.91%
Market Cap
$24.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$28.43M
Operating Margin
-40856.32%
TTM Avg
-34877.94%
3Y Avg
-21440.12%
5Y Avg
-14318.78%
Market Cap
$21.90M
Operating Margin
-14.44%
TTM Avg
-13.11%
3Y Avg
-11.14%
5Y Avg
-41.32%
Market Cap
$20.93M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$30.92M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$31.36M
Operating Margin
-113.31%
TTM Avg
-35.98%
3Y Avg
1.15%
5Y Avg
17.00%
Market Cap
$18.82M
Operating Margin
-24.65%
TTM Avg
-26.95%
3Y Avg
-27.41%
5Y Avg
-18.80%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ABVC BioPharma, Inc. (ABVC) | $25.48M | 0.00% | 75.25% | -6082.77% | -3227.91% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -40856.32% | -34877.94% | -21440.12% | -14318.78% |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -14.44% | -13.11% | -11.14% | -41.32% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00% | 0.00% | 0.00% | 0.00% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -113.31% | -35.98% | 1.15% | 17.00% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -24.65% | -26.95% | -27.41% | -18.80% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 376.26% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -16996.85% |
| 2024-09-30 | -77.66% |
| 2024-06-30 | -734.24% |
| 2024-03-31 | -235539.83% |
| 2023-12-31 | -90605.54% |
| 2023-09-30 | -13566.31% |
| 2023-06-30 | -35911.64% |
| 2023-03-31 | -1486.05% |
| 2022-12-31 | -531.92% |
| 2022-09-30 | -8790.94% |
| 2022-06-30 | -654.24% |
| 2022-03-31 | -24235.08% |
| 2021-12-31 | 17059.12% |
| 2021-09-30 | -1990.48% |
| 2021-06-30 | -6474.08% |
| 2021-03-31 | -476.06% |
| 2020-12-31 | -7799.30% |
| 2020-09-30 | -1116.17% |
| 2020-06-30 | -527.13% |
| 2020-03-31 | -1486.78% |
| 2019-12-31 | -1124.21% |
| 2019-09-30 | -564.21% |
| 2019-06-30 | -254.88% |
| 2019-03-31 | -344.21% |
| 2018-12-31 | -39921.04% |
| 2018-09-30 | -53050.20% |
| 2018-06-30 | -16241.31% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | -2806.36% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | -37.17% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | -2687.52% |
| 2012-12-31 | -1956.08% |
| 2012-09-30 | 800.06% |
| 2012-06-30 | 1814.95% |
| 2012-03-31 | -9019.18% |
| 2011-12-15 | -22401.17% |
| 2011-08-03 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | -45694.44% |
| 2010-12-31 | -14905.95% |
| 2010-09-30 | -11780.10% |
| 2010-05-21 | -11983.03% |
| 2010-02-08 | -7833.77% |
| 2009-12-31 | -14350.89% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | -7664.45% |
| 2008-12-31 | 2120.97% |
| 2008-09-30 | -508563.94% |
| 2008-06-30 | -32372.69% |
| 2008-03-31 | -14812.33% |
| 2007-12-31 | -13850.81% |
| 2007-09-30 | -12175.00% |
| 2007-06-30 | -5757.67% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | -13172.46% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | -156.15% |
| 2004-12-31 | -349.63% |
| 2004-09-30 | 37.98% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | -593.29% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | -200.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | -100.00% |
